Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses

Science Advances(2021)10.1126/sciadv.abh0319Source: DataRank Database

Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses is a research paper published in Science Advances (2021). On theSindex it has a DataRank of 0. It has been cited 171 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access171 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 18.25)OA: goldTopics (29)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Yufei Xiang ORCID,Natasha L. Tilston‐Lunel ORCID,Linda J. Rennick,Zhe Sang ORCID,William B. Klimstra

Live enrichment

PubMed:34039613 PMC:PMC8153718 OpenAlex:https://openalex.org/W3164436793

National Institute of General Medical Sciences

Grant: 1R35GM137905-01

NIGMS NIH HHS

Grant: R35 GM137905

NIH HHS

Grant: S10 OD026983

FWCI

18.25

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by-nc

journalhttps://www.science.org/doi/pdf/10.1126/sciadv.abh0319?download=true

publisherhttps://www.science.org/doi/pdf/10.1126/sciadv.abh0319?download=true

publisherhttps://syndication.highwire.org/content/doi/10.1126/sciadv.abh0319

publisherhttps://www.science.org/doi/pdf/10.1126/sciadv.abh0319

journalhttps://doi.org/10.1126/sciadv.abh0319

Fields of Study

Inhalation and Respiratory Drug DeliveryInfection Control and VentilationSARS-CoV-2 and COVID-19 Research

MeSH Terms

COVID-19SARS-CoV-2COVID-19 Drug TreatmentAdministration, InhalationAerosolsAnimalsDisease Models, AnimalFemaleMaleMesocricetusPneumonia, ViralViral LoadPandemicsSingle-Domain Antibodies

Keywords

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Syrian hamstersVirologyCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakMedicineImmunologyHamsterPathologyInfectious disease (medical specialty)OutbreakInternal medicine

Additional file 1 of A humanized trivalent Nectin-4-targeting nanobody drug conjugate displays potent antitumor activity in gastric cancer

10.6084/m9.figshare.25844354.v1figshare

Additional file 1 of A humanized trivalent Nectin-4-targeting nanobody drug conjugate displays potent antitumor activity in gastric cancer

10.6084/m9.figshare.25844354figshare